Intersect ENT
XENT
#5990
Rank
โ‚น88.26 B
Marketcap
โ‚น2,610
Share price
0.00%
Change (1 day)
24.78%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: โ‚น9.86 Billion

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is โ‚น9.86 Billion. In 2021 the company made a revenue of โ‚น9.86 Billion an increase over the revenue in the year 2020 that were of โ‚น7.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021โ‚น9.86 B32.52%
2020โ‚น7.44 B-26.19%
2019โ‚น10.08 B0.62%
2018โ‚น10.02 B12.64%
2017โ‚น8.90 B22.35%
2016โ‚น7.27 B27.79%
2015โ‚น5.69 B59.62%
2014โ‚น3.56 B115.2%
2013โ‚น1.65 B205.83%
2012โ‚น0.54 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
โ‚น5.15 B-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
โ‚น748.97 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
โ‚น7.47 B-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น122.74 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA